🌙

中国制药企业的协作战略预见与新产品开发

Collaborative Strategic Foresight and New Product Development in Chinese Pharmaceutical Firms

IEEE Transactions on Engineering Management · 2020
被引 22
ABS 3

中文导读

研究两家中国制药企业如何通过协作战略预见支持新产品开发,发现企业所有制影响其采用探索性或利用性协作方式。

Abstract

We integrate insights from open innovation and collaborative strategic foresight (CSF) to theorize collaborative innovation practice. Adopting a case-based approach, we draw qualitative insights from two Chinese pharmaceutical firms—one private and one state-owned, both engaged in new product development (NPD) projects. Focusing on how firms leverage CSF to support their NPD, we offer an interpretive account of how the two firms take different approaches to orchestrating their strategic partnerships to identify, explore, and exploit opportunities for innovation. This article sheds light on how focal firms, through SF practices of perceiving, prospecting, and probing, translate ideas and insights gained from collaborating partners into action to support their innovation processes. Expanding and shifting the focus of traditional strategic foresight from an inward-looking orientation to an outward-looking CSF, we show how focal firms could tap into distributed knowledge embedded in sources located beyond the theoretical boundaries of the firm. We argue that appropriately managed CSF at different stages of NPD could help companies to better sense, seize, and integrate potentialities and limits otherwise overlooked by their competitors. We reveal that the type of ownership, an unexplored factor, explains a firm's different CSF approaches (explorative versus exploitative) in innovation for NPD.

新产品开发开放式创新战略预见制药行业企业所有制